CA46975-1A - 0x000000000000691F

Healthy Males & Females

Refresh

* Stipend may pay up to reflected amount.
Start Date: 
January 7, 2026 - 1:45pm
End Date: 
January 23, 2026 - 8:15am

Study Details

Study Number: CA46975
Group Number: 1A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $5,500.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat of atopic dermatitis (AD).
Route of Administration: Oral
Blood Draws: 20

Study Schedule

Schedule Type: Long Term
Study Length: 9 Night Stay & 1 Return

Screening Dates:

Event Day Event Date
Tuesday 12/30/2025
Friday 1/2/2026
Monday 1/5/2026
Tuesday 1/6/2026
Wednesday 1/7/2026

Doctor Exam Dates:

Event Day Event Date
Tuesday 12/30/2025
Friday 1/2/2026
Monday 1/5/2026
Tuesday 1/6/2026
Wednesday 1/7/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 1/7/2026 1:45:00 PM Friday 1/16/2026 8:30:00 AM 1 Lincoln
Return Friday 1/23/2026 7:15:00 AM Friday 1/23/2026 8:15:00 AM 1 Lincoln